Replies to post #690254 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Not really sure how this is relevant to my comment, which is about press coverage or lack of it for many companies behind many drugs, including well known companies but especially those that are penny stocks. Coverage of new drugs and research is still a valuable thing and if it did not happen, no one would invest in these companies, so it does get through to some audience. The challenge is when such a company and its investors constantly claim they are being shorted, it probably will make new investors think twice, whether true or not.

So the narrative frequently drives these stocks. AMC and GME have an advantage. They are not cutting edge, but lots of small investors can buy calls and that puts pressure on shorts there. NWBO is not a mainstream stock, in a major exchange, so there are no options. We have to rely upon a discounted stock and news that transforms perceptions.